Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
about
Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011)Influence on Adiposity and Atherogenic Lipaemia of Fatty Meals and Snacks in Daily Life.Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial.Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humansAn Updated Review of Interventions that Include Promotion of Physical Activity for Adult Men.Association of Dietary Proportions of Macronutrients with Visceral Adiposity Index: Non-Substitution and Iso-Energetic Substitution Models in a Prospective Study.Differential Effects of Bariatric Surgery Versus Exercise on Excessive Visceral Fat Deposits.A novel use of structural equation models to examine factors associated with prediabetes among adults aged 50 years and older: National Health and Nutrition Examination Survey 2001-2006Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men.Predictors of improvement in cardiometabolic risk factors with weight loss in women.Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity.Distribution of abdominal obesity and fitness level in overweight and obese korean adults.The relative contributions of the abdominal visceral and subcutaneous fat depots to cardiometabolic risk in youthFatty acid composition in serum cholesterol esters and phospholipids is linked to visceral and subcutaneous adipose tissue content in elderly individuals: a cross-sectional study.Metabolic syndrome and lifestyle modification.Paradoxical dissociation between heart rate and heart rate variability following different modalities of exercise in individuals with metabolic syndrome: The RESOLVE study.What Can We Learn from Interventions That Change Fat Distribution?Associations between physical activity and BMI, body fatness, and visceral adiposity in overweight or obese Latino and non-Latino adults.Effects of visceral adipose tissue reduction on CVD risk factors independent of weight loss: The Look AHEAD study.Assessing and targeting key lifestyle cardiovascular risk factors at the workplace: Effect on hemoglobin A1c levels.Interrelationships between changes in anthropometric variables and computed tomography indices of abdominal fat distribution in response to a 1-year physical activity-healthy eating lifestyle modification program in abdominally obese men.Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men.Changes in both global diet quality and physical activity level synergistically reduce visceral adiposity in men with features of metabolic syndrome.Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.Different Associations of Trunk and Lower-Body Fat Mass Distribution with Cardiometabolic Risk Factors between Healthy Middle-Aged Men and Women.Is There a Role for Visceral Adiposity in Inducing Type 2 Diabetes Remission in Severely Obese Patients Following Biliopancreatic Diversion with Duodenal Switch Surgery?[Liver volume, intrahepatic fat and body weight in the course of a lifestyle interventional study: Analysis with quantitative MR-based methods].Liraglutide effect on epicardial fat: Missing the forest for the trees.Androgens, body fat Distribution and Adipogenesis.Association Between Visceral Fat Accumulation and Exercise Tolerance in Non-Obese Subjects Without Diabetes.
P2860
Q33604348-A3B9C443-FB6F-4006-A97D-7F770194C7A4Q33863703-69F09574-7945-460B-857C-8E8B39D22EACQ34152828-0D3761CB-2B85-465B-BD04-A89BF28F801AQ34430537-C0D22BA6-3BDE-4274-A00D-E573401D06D9Q35456943-E988A261-60B9-461F-BDE3-49CDB4294514Q36246852-39699481-C8A8-4400-8E26-3388AA426CAFQ36566835-65232796-4DC4-4A09-B847-0FDE48A8B3BDQ37106601-80B28982-AEF5-46CB-AB25-7EA6A54C695BQ37193579-52B4F824-B4EF-442F-92F2-CE70D11FD9F7Q37457793-66DBDC19-D6FC-48C1-820A-328AED51687BQ37582756-CED311A9-F3EC-47B4-B3F8-2B4D16937E38Q37644885-EFF7B42A-DB0B-4ECE-AE73-F1B572751ED3Q37661174-CCB47466-114E-43BF-8CEE-72BEA9051F0AQ37736703-D5916EC4-A0DA-49FE-83D2-ED8CAEC2E5D3Q38255049-2F646BFB-6B5D-4E95-B99E-8ED77A81FEEEQ38384553-87CC5D85-28BB-40CD-8CAD-038CFC22EE7BQ38801156-1A50A305-70B8-4006-90AD-F4E0E645CA50Q38951130-35972CBD-D573-4FD7-AB3E-B85D6901CFB5Q39649756-8618675F-087E-4D08-81C0-B2B69EDDD3B9Q41145423-1D3A42B6-D5AC-4900-81A8-868712F30990Q44901014-88673870-4737-4DA2-8E10-5DE11ADDFB19Q47247626-564DB75E-1505-404E-82FB-39181EAC3C3CQ48168832-1E9ECB12-4C43-47D9-9A25-96E4DF22A7F8Q50952083-5F870E3E-17BF-4ECD-999D-9200CE049640Q51316416-944F7FE8-5E72-4CB2-9C02-C0131323AA44Q52659358-E18454AE-29E6-4028-93C7-833034EC8FC7Q52986950-6C8B3B41-0CD7-44D1-BBE0-B49F80F931BEQ53579496-3C5B7E84-3F1D-42B8-9363-6F6C6AFCFFEAQ54518821-22798BAA-F0BF-44AD-9926-9CDE80EA7D08Q54569521-7C2FD065-7CCE-47A5-98FD-80D30F027E58Q55426672-1558E3BE-C173-4317-9455-6009E6F7C541
P2860
Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Visceral and not subcutaneous ...... ifestyle modification program.
@en
Visceral and not subcutaneous ...... ifestyle modification program.
@nl
type
label
Visceral and not subcutaneous ...... ifestyle modification program.
@en
Visceral and not subcutaneous ...... ifestyle modification program.
@nl
prefLabel
Visceral and not subcutaneous ...... ifestyle modification program.
@en
Visceral and not subcutaneous ...... ifestyle modification program.
@nl
P2093
P2860
P50
P356
P1433
P1476
Visceral and not subcutaneous ...... ifestyle modification program.
@en
P2093
Jean Bergeron
Jessica Smith
Julie-Anne Nazare
Natalie Alméras
Paul Poirier
P2860
P304
P356
10.1038/OBY.2011.396
P577
2012-01-19T00:00:00Z